Showing results (1-10 of 10) with videos related to
Sort By:
Pageof 1
Tuberculosis (Edinburgh, Scotland)|January 5, 2025
Analogue of the natural product ecumicin causes sustained growth inhibition of Mycobacterium tuberculosis under multiple growth conditionsMaxwell T Stevens, Paige M E Hawkins, Trixie Wang, et al.Vaccines|February 24, 2024
Lung IL-17A-Producing CD4+ T Cells Correlate with Protection after Intrapulmonary Vaccination with Differentially Adjuvanted Tuberculosis VaccinesErica L Stewart, Claudio Counoupas, Diana H Quan, et al.Pharmaceutical Research|January 12, 2026
Efficacy of Inhalable Endolysin Cpl-1 Formulations in Combination with Gentamicin or Endolysin Pal in a Murine Lung Infection ModelYuncheng Wang, Maxwell T Stevens, Trixie Wang, et al.European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|March 6, 2025
Beta-lactam combination treatment overcomes rifampicin resistance in Mycobacterium tuberculosisDiana H Quan, Trixie Wang, Elena Martinez, et al.Journal of Applied Microbiology|October 12, 2024
Synergistic oral beta-lactam combinations for treating tuberculosisDiana H Quan, Trixie Wang, Elena Martinez, et al.Ebiomedicine|February 16, 2025
An LNP-mRNA vaccine modulates innate cell trafficking and promotes polyfunctional Th1 CD4+ T cell responses to enhance BCG-induced protective immunity against Mycobacterium tuberculosisHannah Lukeman, Hareth Al-Wassiti, Stewart A Fabb, et al.Advanced Healthcare Materials|December 9, 2024
Mn and Zn-Doped Multivariate Metal-Organic Framework as a Metalloimmunological Adjuvant to Promote Protection Against Tuberculosis InfectionThomas S Howlett, Sneha Kumari, Ryanne N Ehrman, et al.Journal of Medicinal Chemistry|March 16, 2022
Potent Bactericidal Antimycobacterials Targeting the Chaperone ClpC1 Based on the Depsipeptide Natural Products Ecumicin and Ohmyungsamycin APaige M E Hawkins, David M Hoi, Chen-Yi Cheung, et al.Nature Communications|January 29, 2026
ClpC1-targeting peptide natural products differentially dysregulate the proteome of Mycobacterium tuberculosisIsabel K Barter, Max J Bedding, Julia Leodolter, et al.Molecules (Basel, Switzerland)|November 21, 2020
A Novel Purification Procedure for Active Recombinant Human DPP4 and the Inability of DPP4 to Bind SARS-CoV-2Cecy R Xi, Arianna Di Fazio, Naveed Ahmed Nadvi, et al.Pageof 1